Why is homeopathy still reimbursed ?Le Monde (Medicine supplement p4) on Wednesday published an article asking why France is the only country to reimburse homeopathy, while Le Figaro (website) said that "the wind is changing" in the minds of the French authorities over this matter.
Two nicotine-based patches reimbursedTuesday’s Les Echos (website) and La Croix (brief p7) reported that France has accepted the reimbursement of two smoking cessation products, Nicotine EG (EG Labo) and NicoretteSkin (Johnson & Johnson).
Eczema treatment could be efficient against asthmaWednesday’s L’Humanité (brief p2) and 20 Minutes (website) reported that Sanofi and Renegeron’s dermatitis drug Dupixent has proved efficient against asthma in a study published in the New England Journal of Medicine.
Elsalys goes public to boost immunotherapy developmentBiotech company Elsalys, which specialises in immunotherapy, has announced its intention to launch an IPO in order to finance further development of its immunotherapy candidate Leukotac, Les Echos (p29) announced on Tuesday.
Flash Therapeutics tests gene repair technologyFrench start-up Flash Therapeutics has raised €3.3 million that it will use to further develop its gene repair technologies, Les Echos (p29) wrote on Tuesday.
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.